medRxiv最新文献

筛选
英文 中文
Lung function may recover after exposure to smoke from a coal mine fire: cohort study 接触煤矿火灾烟雾后肺功能可能会恢复:队列研究
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.29.24311157
N. Holt, C. L. Smith, C. X. Gao, B. Borg, T. J. Lane, D. Brown, J. Ikin, A. Makar, T. McCrabb, M. Thomas, K. Nilsen, B. Thompson, M. Abramson
{"title":"Lung function may recover after exposure to smoke from a coal mine fire: cohort study","authors":"N. Holt, C. L. Smith, C. X. Gao, B. Borg, T. J. Lane, D. Brown, J. Ikin, A. Makar, T. McCrabb, M. Thomas, K. Nilsen, B. Thompson, M. Abramson","doi":"10.1101/2024.07.29.24311157","DOIUrl":"https://doi.org/10.1101/2024.07.29.24311157","url":null,"abstract":"Background and objective: The 2014 Hazelwood coalmine fire exposed residents in nearby Morwell to high concentrations of particulate matter <2.5 m (PM2.5) for approximately 6 weeks. This analysis aimed to evaluate the long-term impact on respiratory health. Methods: Adults from Morwell and the unexposed town of Sale completed validated respiratory questionnaires and performed spirometry, gas transfer and oscillometry 3.5-4 years (Round 1) and 7.3-7.8 years (Round 2) after the fire. Individual PM2.5 exposure levels were estimated using chemical transport models mapped onto participant-reported time-location data. Mixed-effects regression models were fitted to analyse associations between PM2.5 exposure and outcomes, controlling for key confounders. Results: From 519 (346 exposed) Round 1 participants, 329 (217 exposed) participated in Round 2. Spirometry and gas transfer in Round 2 were mostly lower compared with Round 1, excepting FVC (increased) and FEV1 (minimal change). The effect of mine fire-related PM2.5 exposure changed from a negative effect in Round 1 to no effect in Round 2 for both pre- (p=0.005) and post-bronchodilator FVC (p=0.032). PM2.5 was not associated with gas transfer in either round. For post-bronchodilator reactance and area under the curve, a negative impact of PM2.5 in Round 1 showed signs of recovery in Round 2 (both p<0.001). Conclusion: In this novel study evaluating long-term respiratory outcomes after medium-duration high concentration PM2.5 exposure, the attenuated associations between exposure and respiratory function may indicate some recovery in lung function. With increased frequency and severity of landscape fires observed globally, these results inform public health policies and planning.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anticoagulation Usage and Thrombolytic Therapy in Subjects with Atrial Fibrillation Associated Ischaemic Stroke. 心房颤动伴缺血性中风患者的抗凝用法和溶栓疗法
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.28.24311145
J. Harbison, J. McCormack, O. Brych, R. Collins, N. O’Connell, P. J. Kelly, T. Cassidy
{"title":"Anticoagulation Usage and Thrombolytic Therapy in Subjects with Atrial Fibrillation Associated Ischaemic Stroke.","authors":"J. Harbison, J. McCormack, O. Brych, R. Collins, N. O’Connell, P. J. Kelly, T. Cassidy","doi":"10.1101/2024.07.28.24311145","DOIUrl":"https://doi.org/10.1101/2024.07.28.24311145","url":null,"abstract":"Atrial Fibrillation (AF) has been Identified as the single largest cause of ischaemic stroke in the Irish population. Previous research showed that widespread adoption of Direct Oral Anticoagulant (DOAC) prophylaxis had not been associated with a reduction in AF associated stroke prevalence. The Irish National Audit of Stroke (INAS) undertook a more detailed study to determine the characteristics of anticoagulation practice in AF associated stroke particularly adherence to prescribing guidelines and effect on thrombolysis rate. Methods: Data from INAS were analysed for the period 2017-2022 inclusive. An enhanced dataset with additional questions about adherence with prescription and International Normalized Ratio (INR) control was collected for 2022 was also considered separately. Results. Complete AF Data were available on 22485 of 26829 incidents admitted over this period. Of these, 19260 (85.6%) were ischaemic strokes, mean age was 71.8 and 57.1% were male. In 5321 of these cases, the AF was identified and in 2835 (53.3%) recognized before the stroke and 2281 (80.4%) had been prescribed anticoagulation. The population with previously unknown AF were significantly younger on average than those on anticoagulation (76.8 years vs. 79.1 years (p<0.0001, t-test)), Group C; 78.8 years (p<0.0001), they were also much more likely to have received thrombolysis (17.3 % vs. 4.0% (Chi Sq, p<0.0001)). There were 4999 stroke in 2022, 4272 (85.4%) were ischemic and 1270 (29.7%) of these were AF associated. Of the 660 total strokes, 597 (90.5%) anticoagulated at presentation were receiving DOACs, of which 557 were ischaemic. Forty-eight (9.5%) had their anticoagulation paused and 40 admitted to poor compliance (7.9%). Conclusion. Nearly half of people with AF detected after stroke was previously unknown. Those with known AF were mainly appropriately treated with DOACs and constitute breakthrough strokes. Subjects receiving DOACs were much less likely to receive thrombolytic therapy even than those taking Warfarin.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796759","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loss of heterozygosity in gastric cancers in a set of Mexican patients 一组墨西哥患者胃癌中的杂合性缺失
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.29.24311063
V. Larios-Serrato, Hilda A. Valdez-Salazar, Javier Torres, M. Camorlinga-Ponce, P. Piña-Sánchez, Fernando Minauro-Sanmiguel, M. Ruiz-Tachiquín, Dr Martha-Eugenia Ruiz-Tachiquín, Av, Cuauhtémoc, Colonia
{"title":"Loss of heterozygosity in gastric cancers in a set of Mexican patients","authors":"V. Larios-Serrato, Hilda A. Valdez-Salazar, Javier Torres, M. Camorlinga-Ponce, P. Piña-Sánchez, Fernando Minauro-Sanmiguel, M. Ruiz-Tachiquín, Dr Martha-Eugenia Ruiz-Tachiquín, Av, Cuauhtémoc, Colonia","doi":"10.1101/2024.07.29.24311063","DOIUrl":"https://doi.org/10.1101/2024.07.29.24311063","url":null,"abstract":"Worldwide, gastric cancer (GC) is a common malignancy with the highest mortality rate among digestive system diseases. The present study of GC and loss of heterozygosity (LOH) is relevant to understanding tumor biology and establishing essential aspects of cancer. Here, DNA samples from Mexican patients with diffuse GC (DGC), intestinal GC (IGC), or non-atrophic gastritis (NAG; control) were purified, and whole-genome high-density arrays were performed. Posteriorly, LOH was identified among the tissue samples, and cancer genes and signaling pathways were analyzed to determine the most altered. Detailed bioinformatics analysis was developed to associate LOH with the Hallmarks of Cancer according to their frequency in patient samples, participation in metabolic pathways, network interactions, and enrichment of Cancer Hallmark genes. LOH-genes in GC were PTPR, NDUFS3, PAK3, IRAK1, IKBKG, TKTL1, PRPS1, GNAI2, RHOA, MAPKA, and MST1R. Genes that stand out at NAG involve proliferation and growth; those at IGC trigger genomic instability, tissue invasion, metastasis, and arrest of cell death; and those at DGC involve energy metabolism, the destruction of immune evasion, and replicative immortality. Other events, such as sustained angiogenesis, were similar between NAG-IGC-DGC. Together, these are molecular, cellular, and metabolic events that must be monitored in GC patients. Our findings must be validated to develop molecular tests for diagnosis, prognosis, treatment response, and, most importantly, screening tests.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796763","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vertical topography in EEG microstates: Physiology or artifact manifestation? 脑电图微状态中的垂直地形图:生理学还是人工痕迹?
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.29.24311153
T. Jordanek, M. Lamos, R. Mareček
{"title":"Vertical topography in EEG microstates: Physiology or artifact manifestation?","authors":"T. Jordanek, M. Lamos, R. Mareček","doi":"10.1101/2024.07.29.24311153","DOIUrl":"https://doi.org/10.1101/2024.07.29.24311153","url":null,"abstract":"The analysis of EEG microstates is a useful method for exploring large-scale networks and brain dynamics. In addition to the often-reported microstates, or so-called 'canonical microstates', another topography has been reported in the literature - topography with a prominent straight line separating positive and negative values that extends from the nasion to the inion (vertical topography - VT). This topography was also revealed in our simultaneous EEG/fMRI and shielded cabin EEG data collected from 77 participants. Following analyses based on human and phantom data, we conclude that VT partially reflects artifacts caused by unspecified movements of the EEG cap and its metallic components. Our conclusion is supported by evaluation of spatiotemporal characteristics of VT estimated from EEG acquired under various conditions, especially by significant correlation between the framewise displacement (obtained from human EEG/fMRI) and the temporal characteristics of VT. We recommend cautious interpretation of VT when revealed in the data. Its very presence as a resulting topography may affect the spatiotemporal parameters of the other microstates and distorts the shapes of the other topographies.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796397","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Defining Suicidal Thought and Behavior Phenotypes for Genetic Studies 为遗传研究定义自杀思想和行为表型
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.27.24311110
E. T. Monson, S. M. Colbert, O. A. Andreassen, O. O. Ayinde, C. A. Bejan, Z. Ceja, H. Coon, E. DiBlasi, A. Izotova, E. A. Kaufman, M. Koromina, W. Myung, J. I. Nurnberger, A. Serretti, J. Smoller, M. Stein, C. C. Zai, Suicide Working Group of the Psychiatric Genomics , M. Aslan, P. B. Barr, T. Bigdeli, P. D. Harvey, N. Kimbrel, P. R. Patel, Cooperative Studies Program 572, D. Ruderfer, A. R. Docherty, N. Mullins, J. J. Mann
{"title":"Defining Suicidal Thought and Behavior Phenotypes for Genetic Studies","authors":"E. T. Monson, S. M. Colbert, O. A. Andreassen, O. O. Ayinde, C. A. Bejan, Z. Ceja, H. Coon, E. DiBlasi, A. Izotova, E. A. Kaufman, M. Koromina, W. Myung, J. I. Nurnberger, A. Serretti, J. Smoller, M. Stein, C. C. Zai, Suicide Working Group of the Psychiatric Genomics , M. Aslan, P. B. Barr, T. Bigdeli, P. D. Harvey, N. Kimbrel, P. R. Patel, Cooperative Studies Program 572, D. Ruderfer, A. R. Docherty, N. Mullins, J. J. Mann","doi":"10.1101/2024.07.27.24311110","DOIUrl":"https://doi.org/10.1101/2024.07.27.24311110","url":null,"abstract":"Background: Standardized definitions of suicidality phenotypes, including suicidal ideation (SI), attempt (SA), and death (SD) are a critical step towards improving understanding and comparison of results in suicide research. The complexity of suicidality contributes to heterogeneity in phenotype definitions, impeding evaluation of clinical and genetic risk factors across studies and efforts to combine samples within consortia. Here, we present expert and data-supported recommendations for defining suicidality and control phenotypes to facilitate merging current/legacy samples with definition variability and aid future sample creation. Methods: A subgroup of clinician researchers and experts from the Suicide Workgroup of the Psychiatric Genomics Consortium (PGC) reviewed existing PGC definitions for SI, SA, SD, and control groups and generated preliminary consensus guidelines for instrument-derived and international classification of disease (ICD) data. ICD lists were validated in two independent datasets (N = 9,151 and 12,394). Results: Recommendations are provided for evaluated instruments for SA and SI, emphasizing selection of lifetime measures phenotype-specific wording. Recommendations are also provided for defining SI and SD from ICD data. As the SA ICD definition is complex, SA code list recommendations were validated against instrument results with sensitivity (range = 15.4% to 80.6%), specificity (range = 67.6% to 97.4%), and positive predictive values (range = 0.59-0.93) reported. Conclusions: Best-practice guidelines are presented for the use of existing information to define SI/SA/SD in consortia research. These proposed definitions are expected to facilitate more homogeneous data aggregation for genetic and multisite studies. Future research should involve refinement, improved generalizability, and validation in diverse populations.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Causal effect of the gut microbiota on the risk of psychiatric disorders and the mediating role of immunophenotypes 肠道微生物群对精神疾病风险的因果效应以及免疫表型的中介作用
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.29.24311128
Zhisheng Hong, Ao He, Guanglong Huang, Xiaofeng Chen, Xiaoyu Wang, Xiaoyang Li, Hailun Chen, Xinqi Zhao, Ying Xu, Yangheng Xu, Ouyang Pei, Hai Wang, Jiapeng Deng, Pengyu Chen, Xian Zhang, Songtao Qi, Yaomin Li
{"title":"Causal effect of the gut microbiota on the risk of psychiatric disorders and the mediating role of immunophenotypes","authors":"Zhisheng Hong, Ao He, Guanglong Huang, Xiaofeng Chen, Xiaoyu Wang, Xiaoyang Li, Hailun Chen, Xinqi Zhao, Ying Xu, Yangheng Xu, Ouyang Pei, Hai Wang, Jiapeng Deng, Pengyu Chen, Xian Zhang, Songtao Qi, Yaomin Li","doi":"10.1101/2024.07.29.24311128","DOIUrl":"https://doi.org/10.1101/2024.07.29.24311128","url":null,"abstract":"Background: Growing evidence indicates a significant correlation between the gut microbiota, immune system, and psychiatric disorders. Nevertheless, the impacts and interactions of the gut microbiota and immunophenotypes on psychiatric disorders remain unclear. Methods: We utilized a bidirectional Mendelian randomization (MR) study to evaluate the causal associations among the gut microbiota, immunophenotypes, and psychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD), major depressive disorder (MDD), posttraumatic stress disorder (PTSD), schizophrenia (SCZ), and Tourette's syndrome (TS). The primary analysis was conducted using the inverse variance weighted (IVW) method, with several complementary sensitivity analyses being performed to ensure the reliability of the results. Results: Our study reveals significant causal relationships between 22 immunophenotypes, 15 types of gut microbiota, and various psychiatric disorders. We further sought to ascertain whether immunophenotypes act as intermediaries in the pathway from gut microbiota to psychiatric disorders. In particular, three immunophenotypes were identified that mediate the causal effects of different gut microbiota on ADHD. Additionally, one immunophenotype was detected to mediate the causal effects of gut microbiota on PTSD. Conclusions: Our study indicates that immunophenotypes partially mediate the pathway from the gut microbiota to psychiatric disorders.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Baseline correlation between pain, range of motion, disability, and health-related quality of life variables in subjects with frozen shoulder: A cross-sectional study 肩周炎患者的疼痛、活动范围、残疾和健康相关生活质量变量之间的基线相关性:横断面研究
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.29.24311165
F. brindisino, A. Poser, D. Feller, D. Venturin
{"title":"Baseline correlation between pain, range of motion, disability, and health-related quality of life variables in subjects with frozen shoulder: A cross-sectional study","authors":"F. brindisino, A. Poser, D. Feller, D. Venturin","doi":"10.1101/2024.07.29.24311165","DOIUrl":"https://doi.org/10.1101/2024.07.29.24311165","url":null,"abstract":"Frozen shoulder (FS) is a debilitating condition affecting the glenohumeral joint. As FS frequently manifests as a chronic condition, it intensifies pain and leads to disability and to a deterioration in overall quality of life, affecting physical, behavioral, mental, and social dimensions. While the impact of pain on disability is widely acknowledged, recent literature highlights a growing body of evidence indicating the correlation between pain and health-related, social, and mental distress and unfavorable outcomes in patients with FS. Up to day, the need for pain to be avoided or alleviated as much as possible has been challenged, with a paradigm shift from traditional biomedical models of pain towards a biopsychosocial model of pain disorders. Research has further shown that psychological factors might affect the function and quality of life in patients with pain and can modulate the individuals pain experience and therefore may play a role in the development and/or maintenance of chronic pain states. As the current healthcare pathway for subjects suffering from FS often inadequately addresses these healthcare needs, and professionals tend to predominantly concentrate on biological and clinical symptoms, the aim of this study will be to explore correlations among Patient-Reported Outcome Measures (PROMs) for pain, and disability, health-related domains, and ROM measurements in individuals with FS during their initial physiotherapy consultation.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796524","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
MostCare-Based Assessment of Cardiac cycle efficiency in Coronary Artery Disease Patients: High-flow nasal cannula versus standard oxygenation for gastrointestinal endoscopy with sedation. The prospective single-center randomised controlled MEHIS study protocol 基于MostCare的冠心病患者心脏循环效率评估¼ 胃肠道内窥镜检查镇静时高流量鼻插管与标准吸氧的对比。前瞻性单中心随机对照 MEHIS 研究方案
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.27.24311111
F. Xie, M. Jin, T. Ma, X. Zhou, S. Wang
{"title":"MostCare-Based Assessment of Cardiac cycle efficiency in Coronary Artery Disease Patients: High-flow nasal cannula versus standard oxygenation for gastrointestinal endoscopy with sedation. The prospective single-center randomised controlled MEHIS study protocol","authors":"F. Xie, M. Jin, T. Ma, X. Zhou, S. Wang","doi":"10.1101/2024.07.27.24311111","DOIUrl":"https://doi.org/10.1101/2024.07.27.24311111","url":null,"abstract":"Introduction During gastrointestinal endoscopy (GIE) procedures(upper/lower) performed under deep sedation, patients with coronary artery disease(CAD) have poorer tolerance, with higher incidence of hypotension and myocardial ischemia. Patients with CAD should particularly avoid hypoxemia caused by deep sedation and increased oxygen consumption caused by inadequate sedation. Recent data indicate that high-flow nasal oxygen therapy (HFNO) is recommended for preventing hypoxemia in high-risk patients. The data on cardiac cycle efficiency (CCE) from MostCare can be used to assess myocardial oxygen supply-demand balance in patients with CAD. HFNO may potentially improve myocardial oxygen supply during GIE under deep sedation. We hypothesize that compared to standard oxygen therapy (SOT), HFNO could improve CCE in patients with CAD. Methods and analysis The MEHIS (MostCare-Based Assessment of CCE in CAD PatientsHFNO versus SOT for GIE with sedation. The prospective single-center randomised controlled) study is a single-center randomized controlled trial comparing the effects of HFNO and SOT during GIE under deep sedation administered by anaesthesiologists in the procedure room in patients with CAD. Ninety patients will be randomly allocated in a 1:1 ratio to two parallel groups. The primary outcome is the difference in CCE levels between the two groups during sedation. Secondary outcomes are the incidence of hypotension(hypotension defined as a systolic blood pressure below 80 mmHg), values of BNP (brain natriuretic peptide), TnI (troponin I), and lactate levels at 6-12 hours post-operationthe occurrence of hypoxemia defined as SpO2 measurement equal to or below 92%, MostCare hemodynamic parameters excluding the primary outcome, interventions required to maintain upper airway patency, patient agitation episodes (assessed by touching the oxygen supply device), and presence of intraoperative adverse memories postoperatively. Keywords high-flow nasal oxygen therapy (HFNO); cardiac cycle efficiency (CCE); gastrointestinal endoscopy (GIE); coronary artery disease(CAD) Trial registration number ChiCTR2400086887 Strengths and limitations of this study 1. This is the first pragmatic randomized single-center study comparing HFNO to SOT for oxygenating patients with CAD undergoing GIE. 2. In contrast to comparing HFNO with high fraction of inspired oxygen (FiO2) typically used in SOT with low oxygen flow and consequently lower FiO2, this study adjusts gas flows to target roughly the same level of applied FiO2 in both groups. This approach aims to assess whether HFNO can improve CCE through positive end-expiratory pressure and/or dead space washout effects. 3. In SOT group, precise FiO2 cannot be guaranteed. That is why we utilized a pre-existing abacus to achieve the best equivalence. 4. Technically, blinding of practitioners and other nursing staff to the study groups is not feasible. However, the printout of recorded primary outcome measures is produced, allo","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796536","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
EFFECT OF TOBACCO CHEWING ON METABOLIC RISK FACTORS IN NORTH INDIAN ADULT MALES 咀嚼烟草对北印度成年男性代谢风险因素的影响
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.26.24311052
A. Gupta, A. K. Singh, V. Gupta
{"title":"EFFECT OF TOBACCO CHEWING ON METABOLIC RISK FACTORS IN NORTH INDIAN ADULT MALES","authors":"A. Gupta, A. K. Singh, V. Gupta","doi":"10.1101/2024.07.26.24311052","DOIUrl":"https://doi.org/10.1101/2024.07.26.24311052","url":null,"abstract":"Tobacco consumption remains one of the leading preventable causes of morbidity and mortality worldwide. Tobacco use is a major public health concern despite widespread public health efforts and strict regulations. Within the framework of the NCEP ATP-III criteria, the goal of the study was to investigate the effects of tobacco consumption on metabolic risk factors in young adult males. This case-control study comprised of 50 male participants aged 18 to 30 years; 25 male tobacco chewers were assigned to the study group, and 25 males who did not chew tobacco (non-tobacco chewers) were assigned to the control group. Anthropometric and metabolic risk factors that were compared between the study and control groups included waist circumference (WC), blood glucose, serum level of triglycerides (TG) and total cholesterol (TC), Insulin resistance (IR) and the homeostatic model assessment (HOMA) index, which is a measure of IR. The results of the study demonstrated that compared to non-tobacco chewers, tobacco chewers had significantly higher glucose (p=0.026), TC (p=0.0013), insulin (p=0.015), and IR (p=0.027). However, there were no discernible variations in HDL, VLDL, and TG levels, or WC. Nine male tobacco chewers and eight male non-tobacco chewers from the respective groups exhibited metabolic risk based on the NCEP ATP-III criterion of three out of five risk factors. Thus, we draw the conclusion that while tobacco chewers' lipid profiles stayed similar, their TC, hyperglycaemia, hyperinsulinemia, and HOMA Index increased, making them more susceptible to the onset of metabolic syndrome.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Immune Modulation in Solid Tumors: A Phase 1b Study of RO6870810 (BET Inhibitor) and Atezolizumab (PD-L1 Inhibitor) 实体瘤的免疫调节:RO6870810(BET 抑制剂)和 Atezolizumab(PD-L1 抑制剂)的 1b 期研究
medRxiv Pub Date : 2024-07-29 DOI: 10.1101/2024.07.28.24309665
Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, Sabine Wilson, Iakov I Davydov, Nicolas Staedler, José Duarte, Iris Martinez Quetglas, Eveline Nüesch, Marta Cañamero, E. Chesne, George Au-Yeung, Erika Hamilton, Stephanie Lheureux, D. Richardson, Iben Spanggaard, Bruno Gomes, I. Franjkovic, M. DeMario, M. Kornacker, K. Lechner, ID ClinicalTrials.gov
{"title":"Immune Modulation in Solid Tumors: A Phase 1b Study of RO6870810 (BET Inhibitor) and Atezolizumab (PD-L1 Inhibitor)","authors":"Daniel Marbach, Jurriaan Brouer-Visser, Laura Brennan, Sabine Wilson, Iakov I Davydov, Nicolas Staedler, José Duarte, Iris Martinez Quetglas, Eveline Nüesch, Marta Cañamero, E. Chesne, George Au-Yeung, Erika Hamilton, Stephanie Lheureux, D. Richardson, Iben Spanggaard, Bruno Gomes, I. Franjkovic, M. DeMario, M. Kornacker, K. Lechner, ID ClinicalTrials.gov","doi":"10.1101/2024.07.28.24309665","DOIUrl":"https://doi.org/10.1101/2024.07.28.24309665","url":null,"abstract":"Purpose: Bromodomain and extra-terminal domain (BET) inhibitors (BETi) have demonstrated epigenetic modulation capabilities, specifically in transcriptional repression of oncogenic pathways. Preclinical assays suggest that BETi potentially attenuates the PD1/PD-L1 immune checkpoint axis, supporting its combination with immunomodulatory agents. Patients and Methods: A Phase 1b clinical trial was conducted to elucidate the pharmacokinetic and pharmacodynamic profiles of the BET inhibitor RO6870810, as monotherapy and in combination with the PD-L1 antagonist atezolizumab, in patients with advanced ovarian carcinomas and triple-negative breast cancer (TNBC). Endpoints included maximum tolerated dosages, adverse event profiling, pharmacokinetic evaluations, and antitumor activity. Pharmacodynamic and immunomodulatory effects were assessed in tumor tissue (by immunohistochemistry and RNA-seq) and in peripheral blood (by flow cytometry and cytokine analysis). Results: The study was terminated prematurely due to a pronounced incidence of immune-related adverse effects in patients receiving combination of RO6870810 and atezolizumab. Anti-tumor activity was limited to 2 patients (5.6%) showing partial response. Although target engagement was confirmed by established BETi pharmacodynamic markers in both blood and tumor samples, BETi failed to markedly decrease tumor PD-L1 expression and had a suppressive effect on anti-tumor immunity. Immune effector activation in tumor tissue was solely observed with the atezolizumab combination, aligning with this checkpoint inhibitor's recognized biological effects. Conclusions: The combination of BET inhibitor RO6870810 with the checkpoint inhibitor atezolizumab presents an unfavorable risk-benefit profile for ovarian cancer and TNBC (triple-negative breast cancer) patients due to the increased risk of augmented or exaggerated immune reactions, without evidence for synergistic anti-tumor effects.","PeriodicalId":506788,"journal":{"name":"medRxiv","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141796553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信